NCT05554003: Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study
- State
- Under way
- Phase
- Phase 2
- People
- 46 planned
- Started
- 14 Jan 2022
- Primary completion
- 31 Dec 2024
- Arms
- Metronomic Temozolomide
- Results
- None posted
- 14 Jan 2022: Trial started
- 26 Sep 2022: Trial registered